These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1796580)
41. [The strain features of the HIV-1 circulating in the USSR based on data from a study of its properties in cell cultures]. Marennikova SS; Stepanova LG; Nosik MN; Rytik PG; Eremin VF; Matsevich GR; Ianova NN Vopr Virusol; 1991; 36(5):356-61. PubMed ID: 1839479 [TBL] [Abstract][Full Text] [Related]
42. Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection. Lai-Hipp C; Goldberg T; Scott E; Ziman A; Vyas G Transfusion; 2011 Feb; 51(2):333-7. PubMed ID: 20796251 [TBL] [Abstract][Full Text] [Related]
43. The influence of cell culture and storage conditions on HIV-1 infectivity and fusogenic activity. Ongrádi J; Ceccherini-Nelli L; Szilágyi JF; Specter S; Pistello M; Laird HM; Bendinelli M Acta Microbiol Hung; 1992; 39(3-4):207-21. PubMed ID: 1285337 [TBL] [Abstract][Full Text] [Related]
44. Different biological properties of paired HIV-1 isolates from peripheral blood mononuclear cells and cerebrospinal fluid. Fiore JR; Angarano G; Fico C; Monno L; Zimatore GB; Di Stefano M; Fracasso C; Pastore G Acta Neurol (Napoli); 1991 Feb; 13(1):31-6. PubMed ID: 1867129 [TBL] [Abstract][Full Text] [Related]
45. Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells. Chochola J; Yamaguchi Y; Moguilevsky N; Bollen A; Strosberg AD; Stanislawski M Antimicrob Agents Chemother; 1994 May; 38(5):969-72. PubMed ID: 8067778 [TBL] [Abstract][Full Text] [Related]
46. [The detection and quantitative determination of antigens to the human immunodeficiency virus types 1 and 2]. Fediuk NV; Konovalov EE; Loktev VB; Uryvaev LV; Kuliandin SA; Pokrovskiĭ AG Vopr Virusol; 1992; 37(3):135-8. PubMed ID: 1441438 [TBL] [Abstract][Full Text] [Related]
47. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Cloyd MW; Lynn WS Virology; 1991 Apr; 181(2):500-11. PubMed ID: 1901681 [TBL] [Abstract][Full Text] [Related]
48. The cytopathic effect of HIV is associated with apoptosis. Laurent-Crawford AG; Krust B; Muller S; Rivière Y; Rey-Cuillé MA; Béchet JM; Montagnier L; Hovanessian AG Virology; 1991 Dec; 185(2):829-39. PubMed ID: 1683728 [TBL] [Abstract][Full Text] [Related]
49. A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV). Casareale D; Stevenson M; Sakai K; Volsky DJ Virology; 1987 Jan; 156(1):40-9. PubMed ID: 3492810 [TBL] [Abstract][Full Text] [Related]
50. Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. Yahi N; Fantini J; Baghdiguian S; Chermann JC J Virol Methods; 1991; 34(2):193-207. PubMed ID: 1725173 [TBL] [Abstract][Full Text] [Related]
51. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. Tan X; Pearce-Pratt R; Phillips DM J Virol; 1993 Nov; 67(11):6447-52. PubMed ID: 8411347 [TBL] [Abstract][Full Text] [Related]
52. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. Somasundaran M; Robinson HL J Virol; 1987 Oct; 61(10):3114-9. PubMed ID: 2957508 [TBL] [Abstract][Full Text] [Related]
53. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. Stevenson M; Zhang XH; Volsky DJ J Virol; 1987 Dec; 61(12):3741-8. PubMed ID: 3500327 [TBL] [Abstract][Full Text] [Related]
54. Cell killing by ultraviolet-inactivated human immunodeficiency virus. Rasheed S; Gottlieb AA; Garry RF Virology; 1986 Oct; 154(2):395-400. PubMed ID: 3490050 [TBL] [Abstract][Full Text] [Related]
55. Human immunodeficiency virus type 1 productive infection in staurosporine-blocked quiescent cells. Aranda-Anzaldo A; Viza D FEBS Lett; 1992 Aug; 308(2):170-4. PubMed ID: 1499727 [TBL] [Abstract][Full Text] [Related]
56. Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). Dewhurst S; Bresser J; Stevenson M; Sakai K; Evinger-Hodges MJ; Volsky DJ FEBS Lett; 1987 Mar; 213(1):138-43. PubMed ID: 3549356 [TBL] [Abstract][Full Text] [Related]
57. Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines. Lemaître M; Henin Y; Destouesse F; Ferrieux C; Montagnier L; Blanchard A Infect Immun; 1992 Mar; 60(3):742-8. PubMed ID: 1371767 [TBL] [Abstract][Full Text] [Related]
58. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis. Lynn WS; Tweedale A; Cloyd MW Virology; 1988 Mar; 163(1):43-51. PubMed ID: 3126600 [TBL] [Abstract][Full Text] [Related]
59. [The characteristics of the long-term continuous cultivation of a cell line chronically infected with the human immunodeficiency virus type-1]. Mamaeva OA; Pliasunova OA; Proniaeva TR; Pokrovskiĭ AG; Tkachev VK; Karamov EV; Rudneva IA Vopr Virusol; 1991; 36(6):447-50. PubMed ID: 1785175 [TBL] [Abstract][Full Text] [Related]
60. [The biological properties of the HIV isolated from a virus carrier living in the Byelorussian SSR]. Rytik PG; van der Groen G; Eremin VF; Kolomiets ND; Popov SA; Nijs P; Willems V; Verkauteren G; Il'kevich IuG; Lemeshko NN Vopr Virusol; 1990; 35(5):389-90. PubMed ID: 2148458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]